Co-selection may explain high rates of ciprofloxacin non-susceptible Escherichia coli from retail poultry reared without prior fluoroquinolone exposure

Journal of Medical Microbiology

Volumn 62, Issue PART 11, 2013, Pages 1743-1746

  Ingram, Paul Robert ^a,b   Rogers, Benjamin A ^c   Sidjabat, Hanna E ^c   Gibson, Justine S ^d   Inglis, Timothy J J ^a,b  

^a PATHWEST LABORATORY MEDICINE   (Australia)

^b UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^c UNIVERSITY OF QUEENSLAND   (Australia)

^d UNIVERSITY OF QUEENSLAND   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; AMOXICILLIN; CIPROFLOXACIN; COTRIMOXAZOLE; GENTAMICIN; QUINOLONE DERIVATIVE; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; AUSTRALIA; BACTERIUM CONTAMINATION; DRUG EXPOSURE; ENRICHMENT CULTURE; ESCHERICHIA COLI; FOOD INDUSTRY; NONHUMAN; PHYLOGENY; POULTRY; PRIORITY JOURNAL;

ACETYLTRANSFERASES; ANIMALS; ANTI-BACTERIAL AGENTS; AUSTRALIA; CHROMOSOMES, BACTERIAL; CIPROFLOXACIN; CLUSTER ANALYSIS; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; GENE TRANSFER, HORIZONTAL; GENES, BACTERIAL; MOLECULAR TYPING; PHYLOGENY; PLASMIDS; POULTRY; SELECTION, GENETIC; TRANSFORMATION, BACTERIAL;

EID: 84885918219     PISSN: 00222615     EISSN: None     Source Type: Journal    
DOI: 10.1099/jmm.0.062729-0     Document Type: Article

References (19)

1. Barlow, R. & Gobius, K. (2008). Pilot Survey for Antimicrobial Resistant Bacteria in Australian Food. Queensland, Australia: Food Science Australia, for the Australian Government Department of Health and Ageing.
2. Cheng, A. C., Turnidge, J., Collignon, P., Looke, D., Barton, M. & Gottlieb, T. (2012). Control of fluoroquinolone resistance through successful regulation, Australia. Emerg Infect Dis 18, 1453-1460.
3. Clermont, O., Bonacorsi, S. & Bingen, E. (2000). Rapid and simple determination of the Escherichia coli phylogenetic group. Appl Environ Microbiol 66, 4555-4558.
4. CLSI (2010). Performance Standards for Antimicrobial Susceptibility Testing: 20th Informational Supplement M100-S20. Wayne, PA: Clinical and Laboratory Standards Institute.
5. Forcella, C., Alessiani, A., Perilli, M., Zilli, K., Di Giannatale, E. & Amicosante, G. (2010). Characterization of quinolone resistance in Escherichia coli strains of animal origin from Italy. J Chemother 22, 165-168.
6. Fortini, D., Fashae, K., García-Fernández, A., Villa, L. & Carattoli, A. (2011). Plasmid-mediated quinolone resistance and β-lactamases in Escherichia coli from healthy animals from Nigeria. J Antimicrob Chemother 66, 1269-1272.
7. Gyles, C. L. (2008). Antimicrobial resistance in selected bacteria from poultry. Anim Health Res Rev 9, 149-158.
8. Huang, S. Y., Dai, L., Xia, L. N., Du, X. D., Qi, Y. H., Liu, H. B., Wu, C. M. & Shen, J. Z. (2009). Increased prevalence of plasmid-mediated quinolone resistance determinants in chicken Escherichia coli isolates from 2001 to 2007. Foodborne Pathog Dis 6, 1203-1209.
9. JETACAR (2009). The Use of Antibiotics in Food-Producing Animals: Antibiotic-Resistant Bacteria in Animals and Humans. Report of the Joint Expert Technical Advisory Committee on Antibiotic Resistance (JETACAR). Canberra: Biotext.
10. Johnson, J. R., Sannes, M. R., Croy, C., Johnston, B., Clabots, C., Kuskowski, M. A., Bender, J., Smith, K. E., Winokur, P. L. & Belongia, E. A. (2007). Antimicrobial drug-resistant Escherichia coli from humans and poultry products, Minnesota and Wisconsin, 2002-2004. Emerg Infect Dis 13, 838-846.
11. Komp Lindgren, P., Karlsson, A. & Hughes, D. (2003). Mutation rate and evolution of fluoroquinolone resistance in Escherichia coli isolates from patients with urinary tract infections. Antimicrob Agents Chemother 47, 3222-3232.
12. Moniri, R. & Dastehgoli, K. (2005). Fluroquinolone resistant Escherichia coli isolated from healthy broilers with previous exposure to fluoroquinolones: is there a link? Microb Ecol Health Dis 17, 69-74.
13. Novick, R. P. & Richmond, M. H. (1965). Nature and interactions of the genetic elements governing penicillinase synthesis in Staphylococcus aureus. J Bacteriol 90, 467-480.
14. Park, C. H., Robicsek, A., Jacoby, G. A., Sahm, D. & Hooper, D. C. (2006). Prevalence in the United States of aac(69)-Ib-cr encoding a ciprofloxacin-modifying enzyme. Antimicrob Agents Chemother 50, 3953-3955.
15. Pearson, J., Turnidge, J., Franklin, C., Bell, J. & Australian Group on Antimicrobial Resistance (2007). Prevalence of antimicrobial resistances in common pathogenic Enterobacteriaceae in Australia, 2004: report from the Australian Group on Antimicrobial Resistance. Commun Dis Intell Q Rep 31, 106-112.
16. Robicsek, A., Strahilevitz, J., Jacoby, G. A., Macielag, M., Abbanat, D., Hye Park, C., Bush, K. & Hooper, D. C. (2006a). Fluoroquinolonemodifying enzyme: a new adaptation of a common aminoglycoside acetyltransferase. Nat Med 12, 83-88.
17. Robicsek, A., Strahilevitz, J., Sahm, D. F., Jacoby, G. A. & Hooper, D. C. (2006b). qnr prevalence in ceftazidime-resistant Enterobacteriaceae isolates from the United States. Antimicrob Agents Chemother 50, 2872-2874.
18. Sidjabat, H. E., Paterson, D. L., Adams-Haduch, J. M., Ewan, L., Pasculle, A. W., Muto, C. A., Tian, G. B. & Doi, Y. (2009). Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother 53, 4733-4739.
19. Wang, M., Tran, J. H., Jacoby, G. A., Zhang, Y., Wang, F. & Hooper, D. C. (2003). Plasmid-mediated quinolone resistance in clinical isolates of Escherichia coli from Shanghai, China. Antimicrob Agents Chemother 47, 2242-2248.